This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Hannah Bolt, PhD, MBA
Head of Peptide Discovery at AstraZeneca
Speaker

Profile

Dr Hannah Bolt, MBA is Head of Peptide Discovery at AstraZeneca. Hannah is an emerging leader in the peptide pharmaceutical field, with >10 years’ experience in peptide drug discovery and has delivered several peptide candidates that are now moving through clinical phases of development. Hannah champions scientific excellence as a sponsor for the adoption of disruptive and emerging technologies, is an active member of the external chemistry community and a passionate STEM ambassador, mentoring the next generation of scientists.

Agenda Sessions

  • Peptide-Targeted Delivery of Oligonucleotide Therapeutics

    09:05